id	sid	eid	entity	type
ihlr-16574	1	1	the european union	ORG
ihlr-16574	1	2	the united states	GPE
ihlr-16574	1	3	nanomedicine	PERSON
ihlr-16574	1	4	smart medical	ORG
ihlr-16574	1	5	emilee s. preble'	PERSON
ihlr-16574	1	6	i. introduction	PERSON
ihlr-16574	1	7	398	CARDINAL
ihlr-16574	3	1	399	CARDINAL
ihlr-16574	3	2	a. nanotechnology	PERSON
ihlr-16574	4	1	399 1	CARDINAL
ihlr-16574	7	1	399 2	CARDINAL
ihlr-16574	8	1	nanomedicine	PERSON
ihlr-16574	10	1	400	CARDINAL
ihlr-16574	10	2	401	CARDINAL
ihlr-16574	10	3	402 lll	PERSON
ihlr-16574	12	1	405	CARDINAL
ihlr-16574	12	2	a. regulation	PERSON
ihlr-16574	12	3	the united states	GPE
ihlr-16574	13	1	405 1	CARDINAL
ihlr-16574	14	1	fda	ORG
ihlr-16574	14	2	405 2	CARDINAL
ihlr-16574	15	1	407 3	DATE
ihlr-16574	15	2	the united states	GPE
ihlr-16574	15	3	409 4	CARDINAL
ihlr-16574	15	4	the united states	GPE
ihlr-16574	15	5	412	CARDINAL
ihlr-16574	15	6	the european union	ORG
ihlr-16574	16	1	413 1	CARDINAL
ihlr-16574	17	1	413 2	CARDINAL
ihlr-16574	18	1	415 3	CARDINAL
ihlr-16574	18	2	416 4	CARDINAL
ihlr-16574	18	3	focus of research and	ORG
ihlr-16574	19	1	417	CARDINAL
ihlr-16574	19	2	41	CARDINAL
ihlr-16574	20	1	the united states	GPE
ihlr-16574	21	1	417 2	CARDINAL
ihlr-16574	22	1	the european union	ORG
ihlr-16574	22	2	419	CARDINAL
ihlr-16574	22	3	421	CARDINAL
ihlr-16574	23	1	422 1	CARDINAL
ihlr-16574	25	1	422 2	CARDINAL
ihlr-16574	25	2	424 •	CARDINAL
ihlr-16574	25	3	j. d.	PERSON
ihlr-16574	25	4	2009	DATE
ihlr-16574	25	5	indiana university school of law-indianapolis	ORG
ihlr-16574	25	6	b.a.	GPE
ihlr-16574	25	7	2005	DATE
ihlr-16574	25	8	butler university	ORG
ihlr-16574	26	1	398	CARDINAL
ihlr-16574	26	2	indiana	GPE
ihlr-16574	27	1	7:397	TIME
ihlr-16574	27	2	424	CARDINAL
ihlr-16574	33	1	nanomedicine	PERSON
ihlr-16574	34	1	2004	DATE
ihlr-16574	34	2	the european commission	ORG
ihlr-16574	34	3	nanomedicine	PERSON
ihlr-16574	34	4	communication2	PERSON
ihlr-16574	34	5	eu­	NORP
ihlr-16574	35	1	european	NORP
ihlr-16574	36	1	4	CARDINAL
ihlr-16574	36	2	ec	ORG
ihlr-16574	36	3	1	CARDINAL
ihlr-16574	36	4	stan williams	PERSON
ihlr-16574	36	5	quantum science research	ORG
ihlr-16574	36	6	insti­ tutional research	ORG
ihlr-16574	36	7	nov. 1, 2008	DATE
ihlr-16574	37	1	2	CARDINAL
ihlr-16574	37	2	the european commission	ORG
ihlr-16574	37	3	the european union	ORG
ihlr-16574	38	1	european	NORP
ihlr-16574	38	2	eu	ORG
ihlr-16574	40	1	the european commission	ORG
ihlr-16574	40	2	european	NORP
ihlr-16574	41	1	the european commission	ORG
ihlr-16574	41	2	jan. 18, 2009	DATE
ihlr-16574	42	1	3	CARDINAL
ihlr-16574	42	2	european	NORP
ihlr-16574	42	3	jan. 17, 2009	DATE
ihlr-16574	43	1	4	CARDINAL
ihlr-16574	43	2	2010	DATE
ihlr-16574	43	3	nanomedicine	PERSON
ihlr-16574	43	4	399	CARDINAL
ihlr-16574	44	1	the united states	GPE
ihlr-16574	44	2	the food and drug administration	ORG
ihlr-16574	44	3	fda	ORG
ihlr-16574	44	4	nanomedicine	PERSON
ihlr-16574	45	1	w. bush administration	PERSON
ihlr-16574	46	1	bush	PERSON
ihlr-16574	46	2	5	CARDINAL
ihlr-16574	46	3	each year	DATE
ihlr-16574	46	4	of$1.5 billion dollars	MONEY
ihlr-16574	46	5	2009.6	CARDINAL
ihlr-16574	46	6	nanomedicine	ORG
ihlr-16574	46	7	the united states	GPE
ihlr-16574	46	8	the european union	ORG
ihlr-16574	47	1	nanomedicine	PERSON
ihlr-16574	48	1	us	GPE
ihlr-16574	48	2	eu	ORG
ihlr-16574	49	1	tory	NORP
ihlr-16574	49	2	nanomedicine	ORG
ihlr-16574	51	1	nanomedicine 1	LAW
ihlr-16574	53	1	greek	GPE
ihlr-16574	53	2	one billionth	CARDINAL
ihlr-16574	54	1	8	CARDINAL
ihlr-16574	55	1	1/80,000th	ORDINAL
ihlr-16574	55	2	10	CARDINAL
ihlr-16574	56	1	5	CARDINAL
ihlr-16574	57	1	brian wilhelmi	PERSON
ihlr-16574	57	2	63	CARDINAL
ihlr-16574	57	3	food & drug l.j. 89,	ORG
ihlr-16574	57	4	99	DATE
ihlr-16574	57	5	6	DATE
ihlr-16574	59	1	2007-2009	DATE
ihlr-16574	60	1	7	CARDINAL
ihlr-16574	60	2	m. lupton	PERSON
ihlr-16574	60	3	26	CARDINAL
ihlr-16574	60	4	349	CARDINAL
ihlr-16574	60	5	350	CARDINAL
ihlr-16574	60	6	2007	DATE
ihlr-16574	61	1	8	CARDINAL
ihlr-16574	63	1	bbc news science	ORG
ihlr-16574	63	2	400	CARDINAL
ihlr-16574	63	3	indiana health law review	ORG
ihlr-16574	66	1	two	CARDINAL
ihlr-16574	66	2	biology.14	ORG
ihlr-16574	66	3	2	CARDINAL
ihlr-16574	67	1	nanomedicine	PERSON
ihlr-16574	68	1	the national institute for health	ORG
ihlr-16574	68	2	nih	ORG
ihlr-16574	68	3	defines nanomedicine	PERSON
ihlr-16574	69	1	european	NORP
ihlr-16574	69	2	etpi8	ORG
ihlr-16574	70	1	nanomedicine	PERSON
ihlr-16574	72	1	today	DATE
ihlr-16574	73	1	•	CARDINAL
ihlr-16574	74	1	10	CARDINAL
ihlr-16574	75	1	lupton	GPE
ihlr-16574	75	2	7	CARDINAL
ihlr-16574	75	3	350	CARDINAL
ihlr-16574	75	4	11	CARDINAL
ihlr-16574	76	1	351	CARDINAL
ihlr-16574	76	2	12	CARDINAL
ihlr-16574	78	1	jd 13	ORG
ihlr-16574	79	1	lupton	ORG
ihlr-16574	79	2	7	CARDINAL
ihlr-16574	79	3	351	CARDINAL
ihlr-16574	79	4	14	CARDINAL
ihlr-16574	80	1	15	CARDINAL
ihlr-16574	82	1	16	CARDINAL
ihlr-16574	84	1	17	CARDINAL
ihlr-16574	85	1	nih	ORG
ihlr-16574	85	2	nanomedicine	PERSON
ihlr-16574	85	3	nov. 8, 2008	DATE
ihlr-16574	86	1	18	CARDINAL
ihlr-16574	87	1	etp	ORG
ihlr-16574	88	1	european	NORP
ihlr-16574	88	2	mar. 14, 2009	DATE
ihlr-16574	89	1	19	CARDINAL
ihlr-16574	89	2	european	NORP
ihlr-16574	89	3	nov. 8, 2008	DATE
ihlr-16574	90	1	20	CARDINAL
ihlr-16574	91	1	lupton	GPE
ihlr-16574	91	2	7	CARDINAL
ihlr-16574	91	3	351	CARDINAL
ihlr-16574	91	4	2010	DATE
ihlr-16574	91	5	nanomedicine 401	PERSON
ihlr-16574	91	6	nanomedicine	PERSON
ihlr-16574	92	1	carlo montemagno	PERSON
ihlr-16574	92	2	the university of california	ORG
ihlr-16574	95	1	montemagno	PERSON
ihlr-16574	95	2	two	CARDINAL
ihlr-16574	99	1	cur­	NORP
ihlr-16574	100	1	21	CARDINAL
ihlr-16574	103	1	24	CARDINAL
ihlr-16574	104	1	25	CARDINAL
ihlr-16574	106	1	lupton	PERSON
ihlr-16574	107	1	7	CARDINAL
ihlr-16574	107	2	350	CARDINAL
ihlr-16574	107	3	27	CARDINAL
ihlr-16574	109	1	adam keiper	PERSON
ihlr-16574	109	2	2003	DATE
ihlr-16574	109	3	atlantis	PRODUCT
ihlr-16574	109	4	17	DATE
ihlr-16574	109	5	17	DATE
ihlr-16574	110	1	28	CARDINAL
ihlr-16574	111	1	24-5	DATE
ihlr-16574	111	2	29	CARDINAL
ihlr-16574	113	1	25	CARDINAL
ihlr-16574	113	2	30	CARDINAL
ihlr-16574	113	3	http://www.mayoclinic.com/health/cancer-survivor/ca00073 oast	PERSON
ihlr-16574	113	4	jan. 18, 2009	DATE
ihlr-16574	114	1	402	CARDINAL
ihlr-16574	114	2	indiana	GPE
ihlr-16574	116	1	years	DATE
ihlr-16574	118	1	nanomedicine	PERSON
ihlr-16574	120	1	nanomedicine	PERSON
ihlr-16574	125	1	.tess	ORG
ihlr-16574	129	1	nanomedicine	PERSON
ihlr-16574	129	2	reg­	ORG
ihlr-16574	131	1	na­	NORP
ihlr-16574	131	2	na­	NORP
ihlr-16574	131	3	31	DATE
ihlr-16574	132	1	n]ew	PRODUCT
ihlr-16574	134	1	tim utile	PERSON
ihlr-16574	134	2	sanford lewis & pamela lundquist	ORG
ihlr-16574	134	3	2·(2007	CARDINAL
ihlr-16574	135	1	32	CARDINAL
ihlr-16574	136	1	naiwtechnology z'n	PERSON
ihlr-16574	136	2	nov. 2, 2008	DATE
ihlr-16574	137	1	2010	DATE
ihlr-16574	137	2	nanomedicine 403	ORG
ihlr-16574	137	3	physiology.33	GPE
ihlr-16574	137	4	the morning	TIME
ihlr-16574	139	1	nanomedicine	PERSON
ihlr-16574	142	1	36	CARDINAL
ihlr-16574	144	1	pean	NORP
ihlr-16574	144	2	nanomedicine	ORG
ihlr-16574	145	1	37 one	CARDINAL
ihlr-16574	145	2	33	DATE
ihlr-16574	146	1	supra	PERSON
ihlr-16574	146	2	5	CARDINAL
ihlr-16574	146	3	97	DATE
ihlr-16574	147	1	34	CARDINAL
ihlr-16574	148	1	supranote31	PERSON
ihlr-16574	153	1	nanowerk	PERSON
ihlr-16574	153	2	nanomedicine	PERSON
ihlr-16574	153	3	7, 2007	DATE
ihlr-16574	153	4	september 22, 2009	DATE
ihlr-16574	155	1	37	CARDINAL
ihlr-16574	156	1	european	NORP
ihlr-16574	156	2	nanomedicine	ORG
ihlr-16574	156	3	12	CARDINAL
ihlr-16574	156	4	sept. 2005	DATE
ihlr-16574	157	1	38	CARDINAL
ihlr-16574	158	1	rick weiss	PERSON
ihlr-16574	158	2	washington post	ORG
ihlr-16574	158	3	sept. 26, 2006	DATE
ihlr-16574	159	1	a]bout 300	CARDINAL
ihlr-16574	160	1	404	CARDINAL
ihlr-16574	160	2	indiana health law review	ORG
ihlr-16574	162	1	39	CARDINAL
ihlr-16574	169	1	robert a. freitas	PERSON
ihlr-16574	169	2	41	CARDINAL
ihlr-16574	170	1	hundreds	CARDINAL
ihlr-16574	171	1	hours	TIME
ihlr-16574	171	2	nanomedicine	PERSON
ihlr-16574	173	1	nanomedicine	ORG
ihlr-16574	174	1	nanomedicine	PERSON
ihlr-16574	175	1	39	CARDINAL
ihlr-16574	176	1	36	CARDINAL
ihlr-16574	177	1	40	DATE
ihlr-16574	178	1	41	CARDINAL
ihlr-16574	179	1	robert a. freitas jr ....	PERSON
ihlr-16574	179	2	first	ORDINAL
ihlr-16574	180	1	•.	ORG
ihlr-16574	181	1	first	ORDINAL
ihlr-16574	181	2	medical nanorobotics	ORG
ihlr-16574	181	3	robert a. frietas jr.	PERSON
ihlr-16574	181	4	mar. 12, 2009	DATE
ihlr-16574	182	1	42	CARDINAL
ihlr-16574	182	2	keiper	PERSON
ihlr-16574	182	3	supra	PERSON
ihlr-16574	182	4	27	CARDINAL
ihlr-16574	182	5	25	CARDINAL
ihlr-16574	183	1	43	DATE
ihlr-16574	185	1	d. 45.	PERSON
ihlr-16574	187	1	46	DATE
ihlr-16574	188	1	2010	DATE
ihlr-16574	188	2	nanomedicine 405	PERSON
ihlr-16574	190	1	47 iii	QUANTITY
ihlr-16574	190	2	a. regulation	PERSON
ihlr-16574	190	3	the united states	GPE
ihlr-16574	190	4	december 3, 2003	DATE
ihlr-16574	190	5	george w. bush	PERSON
ihlr-16574	190	6	nanote­ chology research	ORG
ihlr-16574	190	7	four years	DATE
ihlr-16574	190	8	fiscal year	DATE
ihlr-16574	190	9	2005.49	CARDINAL
ihlr-16574	190	10	ten	CARDINAL
ihlr-16574	190	11	approximately $849	MONEY
ihlr-16574	190	12	the last three years	DATE
ihlr-16574	191	1	fiscal year 2009	DATE
ihlr-16574	191	2	$1.5 billion dollars	MONEY
ihlr-16574	192	1	52	CARDINAL
ihlr-16574	193	1	1	CARDINAL
ihlr-16574	193	2	fda	ORG
ihlr-16574	193	3	fda	ORG
ihlr-16574	193	4	the united states	GPE
ihlr-16574	193	5	american	NORP
ihlr-16574	194	1	54	CARDINAL
ihlr-16574	194	2	fda	ORG
ihlr-16574	195	1	55	CARDINAL
ihlr-16574	195	2	fda	ORG
ihlr-16574	195	3	nanomedicine	ORG
ihlr-16574	195	4	47	CARDINAL
ihlr-16574	196	1	anisa mnyusiwalla	PERSON
ihlr-16574	196	2	abdallah s. daar &	PERSON
ihlr-16574	196	3	peter a. singer	PERSON
ihlr-16574	196	4	14	CARDINAL
ihlr-16574	196	5	2003	DATE
ihlr-16574	196	6	48	CARDINAL
ihlr-16574	197	1	the white house	ORG
ihlr-16574	197	2	http://www.whitehouse.gov/news/releases/2003/l2/200312037.html	ORG
ihlr-16574	197	3	nov. 2, 2008	DATE
ihlr-16574	198	1	49	DATE
ihlr-16574	199	1	50	CARDINAL
ihlr-16574	201	1	the white house	ORG
ihlr-16574	201	2	nov. 2, 2008	DATE
ihlr-16574	201	3	83%	PERCENT
ihlr-16574	201	4	2001	DATE
ihlr-16574	202	1	52	CARDINAL
ihlr-16574	202	2	nni	ORG
ihlr-16574	202	3	jan. 16, 2009	DATE
ihlr-16574	203	1	53	CARDINAL
ihlr-16574	203	2	u.s. food & drug administration	ORG
ihlr-16574	203	3	fda	ORG
ihlr-16574	203	4	centers & offices	ORG
ihlr-16574	203	5	http:// www.fda.gov/aboutfda/centersoffices/default.htm	GPE
ihlr-16574	203	6	sept. 24, 2009	DATE
ihlr-16574	204	1	fda	ORG
ihlr-16574	205	1	54	CARDINAL
ihlr-16574	207	1	john miller	PERSON
ihlr-16574	207	2	fda	ORG
ihlr-16574	207	3	4	CARDINAL
ihlr-16574	208	1	sci. & tech	ORG
ihlr-16574	209	1	l. rev	PERSON
ihlr-16574	210	1	2003	DATE
ihlr-16574	210	2	fda	ORG
ihlr-16574	211	1	406	CARDINAL
ihlr-16574	211	2	indiana health law review	ORG
ihlr-16574	212	1	fda	ORG
ihlr-16574	213	1	56	CARDINAL
ihlr-16574	213	2	fda	ORG
ihlr-16574	214	1	57	CARDINAL
ihlr-16574	214	2	fda	ORG
ihlr-16574	214	3	fda	ORG
ihlr-16574	215	1	fda	ORG
ihlr-16574	216	1	59	CARDINAL
ihlr-16574	216	2	fda	ORG
ihlr-16574	216	3	fda	ORG
ihlr-16574	216	4	cur­	NORP
ihlr-16574	216	5	fda	ORG
ihlr-16574	217	1	63	CARDINAL
ihlr-16574	218	1	64	CARDINAL
ihlr-16574	218	2	fda	ORG
ihlr-16574	218	3	u.s.	GPE
ihlr-16574	218	4	fda	ORG
ihlr-16574	219	1	fda	ORG
ihlr-16574	220	1	fda	ORG
ihlr-16574	220	2	every day	DATE
ihlr-16574	221	1	56	CARDINAL
ihlr-16574	222	1	jessica k	PERSON
ihlr-16574	222	2	fda	ORG
ihlr-16574	222	3	83	CARDINAL
ihlr-16574	222	4	1063	CARDINAL
ihlr-16574	222	5	1065	CARDINAL
ihlr-16574	223	1	51	CARDINAL
ihlr-16574	223	2	nakissa sadrieh & parvaneh	ORG
ihlr-16574	223	3	fda	ORG
ihlr-16574	223	4	3	CARDINAL
ihlr-16574	223	5	l. & bus	ORG
ihlr-16574	223	6	339	CARDINAL
ihlr-16574	223	7	341	CARDINAL
ihlr-16574	224	1	58	DATE
ihlr-16574	225	1	341	CARDINAL
ihlr-16574	226	1	59	CARDINAL
ihlr-16574	227	1	342	CARDINAL
ihlr-16574	228	1	60	CARDINAL
ihlr-16574	229	1	u.s. food & drug administration	ORG
ihlr-16574	229	2	science & research:	ORG
ihlr-16574	229	3	default.htm	PERSON
ihlr-16574	229	4	nov. 1, 2008	DATE
ihlr-16574	230	1	fda	ORG
ihlr-16574	231	1	61	CARDINAL
ihlr-16574	231	2	sadrieh &	ORG
ihlr-16574	231	3	57	CARDINAL
ihlr-16574	231	4	342	CARDINAL
ihlr-16574	232	1	62	CARDINAL
ihlr-16574	233	1	343	CARDINAL
ihlr-16574	234	1	63	DATE
ihlr-16574	235	1	d. 64	PERSON
ihlr-16574	237	1	344	CARDINAL
ihlr-16574	237	2	2010	DATE
ihlr-16574	238	1	fda	ORG
ihlr-16574	240	1	2	CARDINAL
ihlr-16574	241	1	407	CARDINAL
ihlr-16574	241	2	2006	DATE
ihlr-16574	241	3	fda	ORG
ihlr-16574	243	1	fda	ORG
ihlr-16574	243	2	randall lutter	PERSON
ihlr-16574	243	3	fda	ORG
ihlr-16574	244	1	2007	DATE
ihlr-16574	244	2	1	CARDINAL
ihlr-16574	244	3	2	CARDINAL
ihlr-16574	244	4	fda	ORG
ihlr-16574	244	5	3	CARDINAL
ihlr-16574	244	6	fda	ORG
ihlr-16574	245	1	fda	ORG
ihlr-16574	245	2	cur­	NORP
ihlr-16574	245	3	technology.72	PRODUCT
ihlr-16574	248	1	66	CARDINAL
ihlr-16574	249	1	fda	ORG
ihlr-16574	249	2	60	CARDINAL
ihlr-16574	249	3	67	CARDINAL
ihlr-16574	250	1	supra	PERSON
ihlr-16574	250	2	5	CARDINAL
ihlr-16574	250	3	100	CARDINAL
ihlr-16574	251	1	68	CARDINAL
ihlr-16574	252	1	u.s. food & drug administration	ORG
ihlr-16574	252	2	fda	ORG
ihlr-16574	252	3	http://	CARDINAL
ihlr-16574	253	1	jan. 16, 2009	DATE
ihlr-16574	254	1	69	CARDINAL
ihlr-16574	255	1	fda	ORG
ihlr-16574	255	2	2	CARDINAL
ihlr-16574	255	3	3	CARDINAL
ihlr-16574	255	4	4	CARDINAL
ihlr-16574	255	5	5	CARDINAL
ihlr-16574	255	6	6	CARDINAL
ihlr-16574	255	7	7	CARDINAL
ihlr-16574	255	8	8)	CARDINAL
ihlr-16574	255	9	9	CARDINAL
ihlr-16574	256	1	fda	ORG
ihlr-16574	256	2	53	CARDINAL
ihlr-16574	256	3	supra	PERSON
ihlr-16574	256	4	5	CARDINAL
ihlr-16574	256	5	100	CARDINAL
ihlr-16574	257	1	70	CARDINAL
ihlr-16574	258	1	supra	PERSON
ihlr-16574	258	2	5	CARDINAL
ihlr-16574	258	3	100	CARDINAL
ihlr-16574	258	4	71	CARDINAL
ihlr-16574	259	1	100-01	DATE
ihlr-16574	259	2	72	DATE
ihlr-16574	260	1	101	CARDINAL
ihlr-16574	261	1	73	CARDINAL
ihlr-16574	263	1	408	CARDINAL
ihlr-16574	263	2	indiana health law review	ORG
ihlr-16574	264	1	7:397	CARDINAL
ihlr-16574	264	2	fda	ORG
ihlr-16574	265	1	74	CARDINAL
ihlr-16574	266	1	80	CARDINAL
ihlr-16574	266	2	fda	ORG
ihlr-16574	267	1	fda	ORG
ihlr-16574	268	1	applicable.81	NORP
ihlr-16574	268	2	one	CARDINAL
ihlr-16574	269	1	fda	ORG
ihlr-16574	269	2	nanomedicine	PERSON
ihlr-16574	270	1	nanomedicine	PERSON
ihlr-16574	271	1	74	CARDINAL
ihlr-16574	273	1	102	CARDINAL
ihlr-16574	273	2	75	CARDINAL
ihlr-16574	274	1	76	DATE
ihlr-16574	275	1	supra	PERSON
ihlr-16574	275	2	5	CARDINAL
ihlr-16574	275	3	102	CARDINAL
ihlr-16574	278	1	chun-nm	PERSON
ihlr-16574	278	2	lok et al.	PERSON
ihlr-16574	278	3	12	CARDINAL
ihlr-16574	279	1	527	CARDINAL
ihlr-16574	279	2	2007	DATE
ihlr-16574	281	1	supra	PERSON
ihlr-16574	281	2	5	CARDINAL
ihlr-16574	281	3	102	CARDINAL
ihlr-16574	281	4	79	CARDINAL
ihlr-16574	283	1	103	CARDINAL
ihlr-16574	283	2	80	CARDINAL
ihlr-16574	284	1	u.s.	GPE
ihlr-16574	284	2	food and drug administration	ORG
ihlr-16574	284	3	u.s.	GPE
ihlr-16574	284	4	35	CARDINAL
ihlr-16574	284	5	2007	DATE
ihlr-16574	286	1	81	CARDINAL
ihlr-16574	289	1	19-20	CARDINAL
ihlr-16574	289	2	2010	DATE
ihlr-16574	289	3	nanomedicine 409	PERSON
ihlr-16574	290	1	nanomedicine	PERSON
ihlr-16574	290	2	medi­ cal	GPE
ihlr-16574	291	1	fda	ORG
ihlr-16574	291	2	three	CARDINAL
ihlr-16574	292	1	82	CARDINAL
ihlr-16574	293	1	83	CARDINAL
ihlr-16574	293	2	'substan­	DATE
ihlr-16574	294	1	87	CARDINAL
ihlr-16574	295	1	88	CARDINAL
ihlr-16574	296	1	89	CARDINAL
ihlr-16574	296	2	fda	ORG
ihlr-16574	296	3	ntf	ORG
ihlr-16574	296	4	nanomedicine technology	ORG
ihlr-16574	298	1	3	CARDINAL
ihlr-16574	298	2	the united states	GPE
ihlr-16574	298	3	fda	ORG
ihlr-16574	298	4	u.s.	GPE
ihlr-16574	299	1	one	CARDINAL
ihlr-16574	299	2	nni	PERSON
ihlr-16574	299	3	2001	DATE
ihlr-16574	299	4	82	CARDINAL
ihlr-16574	300	1	83	DATE
ihlr-16574	301	1	84	CARDINAL
ihlr-16574	303	1	d. 86	PERSON
ihlr-16574	304	1	d. 87	PERSON
ihlr-16574	305	1	ntfreport	ORG
ihlr-16574	305	2	80	CARDINAL
ihlr-16574	305	3	at24-5	DATE
ihlr-16574	306	1	25. 89	DATE
ihlr-16574	309	1	d. 90	PERSON
ihlr-16574	310	1	supra	PERSON
ihlr-16574	310	2	5	CARDINAL
ihlr-16574	310	3	102	CARDINAL
ihlr-16574	311	1	91	CARDINAL
ihlr-16574	312	1	nni	PERSON
ihlr-16574	313	1	nov. 2, 2008	DATE
ihlr-16574	314	1	410	CARDINAL
ihlr-16574	314	2	indiana	GPE
ihlr-16574	315	1	7:397	CARDINAL
ihlr-16574	318	1	nni	PRODUCT
ihlr-16574	319	1	nni	PERSON
ihlr-16574	319	2	over 25	CARDINAL
ihlr-16574	319	3	nset	PERSON
ihlr-16574	319	4	nanomedicine.96 nni	PERSON
ihlr-16574	320	1	hasan	PERSON
ihlr-16574	320	2	of$1.5 billion	QUANTITY
ihlr-16574	320	3	the 2009 fiscal year.97	DATE
ihlr-16574	321	1	98	CARDINAL
ihlr-16574	323	1	92	CARDINAL
ihlr-16574	325	1	93	CARDINAL
ihlr-16574	327	1	94	CARDINAL
ihlr-16574	328	1	jan. 16, 2009	DATE
ihlr-16574	329	1	95	CARDINAL
ihlr-16574	331	1	96	CARDINAL
ihlr-16574	331	2	jan. 16, 2009	DATE
ihlr-16574	331	3	97	CARDINAL
ihlr-16574	331	4	2009	DATE
ihlr-16574	332	1	fy09	PERSON
ihlr-16574	333	1	pdf {last visited	ORG
ihlr-16574	333	2	april 21	DATE
ihlr-16574	333	3	201	CARDINAL
ihlr-16574	333	4	2007	DATE
ihlr-16574	335	1	98	CARDINAL
ihlr-16574	335	2	jan. 16, 2009	DATE
ihlr-16574	336	1	2010	DATE
ihlr-16574	336	2	nanomedicine nni	PERSON
ihlr-16574	336	3	national institute of standards	ORG
ihlr-16574	336	4	411	CARDINAL
ihlr-16574	336	5	eight	CARDINAL
ihlr-16574	336	6	nni	PRODUCT
ihlr-16574	336	7	nni	PERSON
ihlr-16574	337	1	national science & technology council	ORG
ihlr-16574	337	2	2009	DATE
ihlr-16574	337	3	1	CARDINAL
ihlr-16574	337	4	february 14, 2010	DATE
ihlr-16574	338	1	100	CARDINAL
ihlr-16574	338	2	http://www.nano.gov/html/about/funding.html	ORG
ihlr-16574	338	3	jan.. 16, 2009	DATE
ihlr-16574	339	1	01	CARDINAL
ihlr-16574	340	1	eight	CARDINAL
ihlr-16574	340	2	1	CARDINAL
ihlr-16574	340	3	2	CARDINAL
ihlr-16574	340	4	3	CARDINAL
ihlr-16574	340	5	4	CARDINAL
ihlr-16574	340	6	5	CARDINAL
ihlr-16574	340	7	6	CARDINAL
ihlr-16574	340	8	7	CARDINAL
ihlr-16574	341	1	nn1	CARDINAL
ihlr-16574	341	2	jan. 16, 2009	DATE
ihlr-16574	342	1	412	CARDINAL
ihlr-16574	342	2	indiana health law review	ORG
ihlr-16574	343	1	the united states	GPE
ihlr-16574	344	1	the international association of nanotechnology	ORG
ihlr-16574	344	2	ian	NORP
ihlr-16574	344	3	california	GPE
ihlr-16574	344	4	busi­ ness	PERSON
ihlr-16574	344	5	nanotechnology?02	CARDINAL
ihlr-16574	344	6	ian	ORG
ihlr-16574	344	7	crn	ORG
ihlr-16574	345	1	103	CARDINAL
ihlr-16574	345	2	crn	ORG
ihlr-16574	345	3	104 crn	PERSON
ihlr-16574	346	1	105 4	DATE
ihlr-16574	347	1	the united states	GPE
ihlr-16574	347	2	nanomedicine	PERSON
ihlr-16574	347	3	the united states	GPE
ihlr-16574	348	1	108	CARDINAL
ihlr-16574	348	2	neg­	ORG
ihlr-16574	348	3	•	CARDINAL
ihlr-16574	349	1	102	CARDINAL
ihlr-16574	350	1	international association of nanotechnology	ORG
ihlr-16574	350	2	nov. 2, 2008	DATE
ihlr-16574	351	1	103	CARDINAL
ihlr-16574	351	2	crn	ORG
ihlr-16574	351	3	nov. 2, 2008	DATE
ihlr-16574	352	1	104	CARDINAL
ihlr-16574	354	1	crn	ORG
ihlr-16574	354	2	2010	DATE
ihlr-16574	355	1	106	CARDINAL
ihlr-16574	357	1	4	CARDINAL
ihlr-16574	357	2	http://www.nanowerlc.comlnanotechnologylnano	ORG
ihlr-16574	357	3	nov. 2, 2008	DATE
ihlr-16574	358	1	107	CARDINAL
ihlr-16574	359	1	nov. 2, 2008	DATE
ihlr-16574	361	1	108	CARDINAL
ihlr-16574	363	1	jan. 16, 2009	DATE
ihlr-16574	364	1	2010	DATE
ihlr-16574	364	2	nanomedicine 413	ORG
ihlr-16574	365	1	110	CARDINAL
ihlr-16574	365	2	nanomedicine	PERSON
ihlr-16574	365	3	111	CARDINAL
ihlr-16574	365	4	nanomedicine	ORG
ihlr-16574	365	5	the european union	ORG
ihlr-16574	365	6	may 12, 2004	DATE
ihlr-16574	365	7	the european union	ORG
ihlr-16574	365	8	eu	ORG
ihlr-16574	365	9	ec	ORG
ihlr-16574	365	10	european	NORP
ihlr-16574	367	1	1	CARDINAL
ihlr-16574	367	2	eu	ORG
ihlr-16574	367	3	eu	ORG
ihlr-16574	368	1	107	CARDINAL
ihlr-16574	368	2	111	CARDINAL
ihlr-16574	369	1	nanotech	ORG
ihlr-16574	369	2	33	DATE
ihlr-16574	369	3	2006	DATE
ihlr-16574	369	4	112	CARDINAL
ihlr-16574	371	1	31	CARDINAL
ihlr-16574	371	2	113	CARDINAL
ihlr-16574	372	1	giorgia guerra	PERSON
ihlr-16574	372	2	european	NORP
ihlr-16574	372	3	nanomedicine	ORG
ihlr-16574	372	4	2	CARDINAL
ihlr-16574	372	5	87	DATE
ihlr-16574	372	6	87	DATE
ihlr-16574	372	7	european	NORP
ihlr-16574	372	8	european	NORP
ihlr-16574	372	9	jan. 17, 2009	DATE
ihlr-16574	373	1	114	CARDINAL
ihlr-16574	373	2	113	CARDINAL
ihlr-16574	373	3	87	DATE
ihlr-16574	375	1	115	CARDINAL
ihlr-16574	376	1	european commission	ORG
ihlr-16574	376	2	eu	ORG
ihlr-16574	377	1	en.htm	ORG
ihlr-16574	377	2	jan. 1"7,	DATE
ihlr-16574	377	3	2009	DATE
ihlr-16574	378	1	116	CARDINAL
ihlr-16574	379	1	d. 117	PERSON
ihlr-16574	381	1	118	CARDINAL
ihlr-16574	383	1	414	CARDINAL
ihlr-16574	383	2	indiana health law review	ORG
ihlr-16574	384	1	7:397	CARDINAL
ihlr-16574	384	2	three	CARDINAL
ihlr-16574	384	3	first	ORDINAL
ihlr-16574	384	4	90/385	CARDINAL
ihlr-16574	386	1	123	CARDINAL
ihlr-16574	388	1	the na­ nites	ORG
ihlr-16574	390	1	124	CARDINAL
ihlr-16574	390	2	second	ORDINAL
ihlr-16574	390	3	di­	PERSON
ihlr-16574	390	4	93/42	CARDINAL
ihlr-16574	391	1	120	CARDINAL
ihlr-16574	392	1	giorgia guerra	PERSON
ihlr-16574	392	2	eu­	NORP
ihlr-16574	392	3	3	CARDINAL
ihlr-16574	392	4	l. & bus	ORG
ihlr-16574	392	5	84	CARDINAL
ihlr-16574	392	6	87	CARDINAL
ihlr-16574	394	1	121	CARDINAL
ihlr-16574	394	2	87	CARDINAL
ihlr-16574	395	1	122	CARDINAL
ihlr-16574	396	1	90/385	CARDINAL
ihlr-16574	397	1	1990	DATE
ihlr-16574	398	1	l 189	DATE
ihlr-16574	398	2	1,3	CARDINAL
ihlr-16574	398	3	http://eur	ORG
ihlr-16574	398	4	1990l0385:20071 011	CARDINAL
ihlr-16574	398	5	pdf	ORG
ihlr-16574	398	6	feb. 24	DATE
ihlr-16574	398	7	201	CARDINAL
ihlr-16574	399	1	123	CARDINAL
ihlr-16574	401	1	d. 125	PERSON
ihlr-16574	402	1	keiper	PERSON
ihlr-16574	402	2	27	CARDINAL
ihlr-16574	402	3	20-1	CARDINAL
ihlr-16574	402	4	kim eric drexler	PERSON
ihlr-16574	403	1	126	CARDINAL
ihlr-16574	404	1	113	CARDINAL
ihlr-16574	404	2	88	DATE
ihlr-16574	405	1	127	CARDINAL
ihlr-16574	406	1	nanomedicine 415	LAW
ihlr-16574	407	1	128	CARDINAL
ihlr-16574	410	1	nanomedicine applications	ORG
ihlr-16574	410	2	di­	PERSON
ihlr-16574	410	3	93/42	CARDINAL
ihlr-16574	411	1	third	ORDINAL
ihlr-16574	411	2	nanomedicine	PERSON
ihlr-16574	411	3	98/79ec	CARDINAL
ihlr-16574	412	1	130	CARDINAL
ihlr-16574	412	2	materi­ al	PERSON
ihlr-16574	413	1	nanomedicine	PERSON
ihlr-16574	414	1	133	CARDINAL
ihlr-16574	414	2	eu	ORG
ihlr-16574	415	1	2	CARDINAL
ihlr-16574	415	2	european	NORP
ihlr-16574	415	3	etp	ORG
ihlr-16574	415	4	etp	PERSON
ihlr-16574	416	1	93/42	CARDINAL
ihlr-16574	417	1	1,1993	CARDINAL
ihlr-16574	417	2	l 169) 1	DATE
ihlr-16574	417	3	5	CARDINAL
ihlr-16574	417	4	http://eur	ORG
ihlr-16574	417	5	l993l 0042:20071011	PERSON
ihlr-16574	417	6	pdf	ORG
ihlr-16574	417	7	nov. 8, 2008	DATE
ihlr-16574	418	1	129	CARDINAL
ihlr-16574	420	1	113	CARDINAL
ihlr-16574	420	2	87-88	DATE
ihlr-16574	421	1	131	CARDINAL
ihlr-16574	422	1	98/79	CARDINAL
ihlr-16574	423	1	1	CARDINAL
ihlr-16574	423	2	1998	DATE
ihlr-16574	424	1	l 331	DATE
ihlr-16574	424	2	1	CARDINAL
ihlr-16574	424	3	7	DATE
ihlr-16574	424	4	pdf	ORG
ihlr-16574	424	5	nov. 8, 2008	DATE
ihlr-16574	425	1	132	CARDINAL
ihlr-16574	427	1	european	NORP
ihlr-16574	427	2	nanomedicine	ORG
ihlr-16574	427	3	15	DATE
ihlr-16574	427	4	sept. 2005	DATE
ihlr-16574	429	1	134	CARDINAL
ihlr-16574	430	1	113	CARDINAL
ihlr-16574	431	1	87-88	DATE
ihlr-16574	432	1	135	CARDINAL
ihlr-16574	434	1	europe	LOC
ihlr-16574	434	2	indiana health law review	ORG
ihlr-16574	435	1	.industry	ORG
ihlr-16574	435	2	the european commission	ORG
ihlr-16574	436	1	53	CARDINAL
ihlr-16574	436	2	european	NORP
ihlr-16574	436	3	european	NORP
ihlr-16574	437	1	first	ORDINAL
ihlr-16574	437	2	2020	DATE
ihlr-16574	438	1	2006	DATE
ihlr-16574	438	2	december 2006	DATE
ihlr-16574	438	3	150	CARDINAL
ihlr-16574	440	1	european	NORP
ihlr-16574	440	2	nanomedicine	PERSON
ihlr-16574	442	1	etp	ORG
ihlr-16574	442	2	2005	DATE
ihlr-16574	442	3	three	CARDINAL
ihlr-16574	442	4	1	CARDINAL
ihlr-16574	442	5	2	CARDINAL
ihlr-16574	442	6	3	CARDINAL
ihlr-16574	442	7	three	CARDINAL
ihlr-16574	442	8	the year 2020	DATE
ihlr-16574	442	9	1	CARDINAL
ihlr-16574	442	10	2	CARDINAL
ihlr-16574	443	1	3	CARDINAL
ihlr-16574	444	1	3	CARDINAL
ihlr-16574	445	1	2005	DATE
ihlr-16574	445	2	etp	ORG
ihlr-16574	445	3	nanomedicine	PERSON
ihlr-16574	446	1	european	NORP
ihlr-16574	446	2	th_e european technology platforms	ORG
ihlr-16574	446	3	mar. 12, 2009	DATE
ihlr-16574	447	1	136	CARDINAL
ihlr-16574	448	1	etp strategic researcha.genda	PERSON
ihlr-16574	448	2	133	CARDINAL
ihlr-16574	448	3	at4	ORG
ihlr-16574	448	4	137	CARDINAL
ihlr-16574	450	1	417	CARDINAL
ihlr-16574	451	1	140	CARDINAL
ihlr-16574	452	1	4	CARDINAL
ihlr-16574	452	2	focus of research and	ORG
ihlr-16574	454	1	nanomedicine research and	ORG
ihlr-16574	454	2	u.s.	GPE
ihlr-16574	454	3	overnanomedicine a.	PERSON
ihlr-16574	454	4	first	ORDINAL
ihlr-16574	454	5	nanomedicine	ORG
ihlr-16574	456	1	1	CARDINAL
ihlr-16574	456	2	the united states	GPE
ihlr-16574	456	3	u.s.	GPE
ihlr-16574	456	4	fda	ORG
ihlr-16574	456	5	139	CARDINAL
ihlr-16574	458	1	140	CARDINAL
ihlr-16574	460	1	36	CARDINAL
ihlr-16574	460	2	142	CARDINAL
ihlr-16574	461	1	six	CARDINAL
ihlr-16574	462	1	133	CARDINAL
ihlr-16574	463	1	143	CARDINAL
ihlr-16574	464	1	57	CARDINAL
ihlr-16574	464	2	340	CARDINAL
ihlr-16574	465	1	418	CARDINAL
ihlr-16574	465	2	indiana heal1h law review	ORG
ihlr-16574	467	1	fda	ORG
ihlr-16574	467	2	twenty-five cents	MONEY
ihlr-16574	467	3	american	NORP
ihlr-16574	468	1	fda	ORG
ihlr-16574	468	2	fda	ORG
ihlr-16574	469	1	fda	ORG
ihlr-16574	470	1	fda	ORG
ihlr-16574	471	1	fda	ORG
ihlr-16574	472	1	one	CARDINAL
ihlr-16574	472	2	fda	ORG
ihlr-16574	474	1	fda	ORG
ihlr-16574	476	1	fda	ORG
ihlr-16574	476	2	at least two	CARDINAL
ihlr-16574	477	1	15l	CARDINAL
ihlr-16574	477	2	na144	PERSON
ihlr-16574	478	1	145	CARDINAL
ihlr-16574	480	1	146	CARDINAL
ihlr-16574	481	1	fda	ORG
ihlr-16574	481	2	60	CARDINAL
ihlr-16574	482	1	14 7	DATE
ihlr-16574	482	2	supra	PERSON
ihlr-16574	482	3	5	CARDINAL
ihlr-16574	482	4	102	CARDINAL
ihlr-16574	482	5	148	CARDINAL
ihlr-16574	484	1	fda	ORG
ihlr-16574	484	2	u.s.	GPE
ihlr-16574	484	3	food and drug administration nanotechnology task	ORG
ihlr-16574	484	4	16	CARDINAL
ihlr-16574	484	5	2007	DATE
ihlr-16574	484	6	nanotecbnologyltaskforcelreport2007	NORP
ihlr-16574	484	7	150	CARDINAL
ihlr-16574	484	8	sadreih &	ORG
ihlr-16574	484	9	57	CARDINAL
ihlr-16574	484	10	344	CARDINAL
ihlr-16574	484	11	2010	DATE
ihlr-16574	484	12	nanomedicine 419	ORG
ihlr-16574	485	1	fda	ORG
ihlr-16574	487	1	2	CARDINAL
ihlr-16574	488	1	the european union	ORG
ihlr-16574	490	1	ec	ORG
ihlr-16574	490	2	eu	ORG
ihlr-16574	491	1	eu	ORG
ihlr-16574	493	1	153	CARDINAL
ihlr-16574	493	2	the eu states	GPE
ihlr-16574	496	1	cur­	NORP
ihlr-16574	498	1	nanomedicine	PERSON
ihlr-16574	499	1	151	CARDINAL
ihlr-16574	500	1	349	CARDINAL
ihlr-16574	500	2	fda	ORG
ihlr-16574	501	1	152	CARDINAL
ihlr-16574	501	2	nanowerk	PERSON
ihlr-16574	501	3	european commission	ORG
ihlr-16574	502	1	oct. 7, 2008	DATE
ihlr-16574	502	2	sept. 29, 2009	DATE
ihlr-16574	503	1	153	CARDINAL
ihlr-16574	504	1	european	NORP
ihlr-16574	504	2	the european economic and social committee	ORG
ihlr-16574	504	3	2008	DATE
ihlr-16574	504	4	366	CARDINAL
ihlr-16574	504	5	1l	CARDINAL
ihlr-16574	504	6	june 17, 2008	DATE
ihlr-16574	506	1	154	CARDINAL
ihlr-16574	508	1	d. 156	PERSON
ihlr-16574	510	1	133	CARDINAL
ihlr-16574	511	1	420	CARDINAL
ihlr-16574	511	2	indiana health law review	ORG
ihlr-16574	512	1	7:397	CARDINAL
ihlr-16574	513	1	158	CARDINAL
ihlr-16574	514	1	eu	PERSON
ihlr-16574	514	2	aw.are	WORK_OF_ART
ihlr-16574	514	3	nanomedicine	PERSON
ihlr-16574	515	1	european	NORP
ihlr-16574	515	2	ben	PERSON
ihlr-16574	517	1	european	NORP
ihlr-16574	518	1	seventh	ORDINAL
ihlr-16574	519	1	163	CARDINAL
ihlr-16574	519	2	fp7	ORG
ihlr-16574	519	3	eu	ORG
ihlr-16574	519	4	four	CARDINAL
ihlr-16574	520	1	164	CARDINAL
ihlr-16574	520	2	the european commission	ORG
ihlr-16574	520	3	european	NORP
ihlr-16574	520	4	mia	PERSON
ihlr-16574	520	5	european	NORP
ihlr-16574	520	6	nanomedicine	PERSON
ihlr-16574	521	1	2006	DATE
ihlr-16574	521	2	three	CARDINAL
ihlr-16574	521	3	158	CARDINAL
ihlr-16574	522	1	24	DATE
ihlr-16574	522	2	159	CARDINAL
ihlr-16574	525	1	at20	ORG
ihlr-16574	526	1	162	CARDINAL
ihlr-16574	527	1	11	CARDINAL
ihlr-16574	527	2	163	CARDINAL
ihlr-16574	528	1	28	CARDINAL
ihlr-16574	528	2	european	NORP
ihlr-16574	529	1	fp7	PERSON
ihlr-16574	529	2	http://cordis.europa.eultp7/understand_en.html	ORG
ihlr-16574	529	3	feb. 12, 2009	DATE
ihlr-16574	530	1	164	CARDINAL
ihlr-16574	531	1	165	CARDINAL
ihlr-16574	533	1	133	CARDINAL
ihlr-16574	534	1	2010	DATE
ihlr-16574	534	2	nanomedicine 421	LAW
ihlr-16574	534	3	first	ORDINAL
ihlr-16574	534	4	only one	CARDINAL
ihlr-16574	534	5	second	ORDINAL
ihlr-16574	535	1	169	CARDINAL
ihlr-16574	535	2	third	ORDINAL
ihlr-16574	535	3	second	ORDINAL
ihlr-16574	535	4	nanomedi­ cine	PERSON
ihlr-16574	536	1	eu	ORG
ihlr-16574	536	2	a[]s	NORP
ihlr-16574	539	1	eu	ORG
ihlr-16574	540	1	fda	ORG
ihlr-16574	543	1	u.s.	GPE
ihlr-16574	543	2	eu	ORG
ihlr-16574	546	1	167	CARDINAL
ihlr-16574	548	1	168	CARDINAL
ihlr-16574	550	1	169	CARDINAL
ihlr-16574	551	1	170	CARDINAL
ihlr-16574	552	1	171	CARDINAL
ihlr-16574	553	1	153	CARDINAL
ihlr-16574	553	2	11	CARDINAL
ihlr-16574	554	1	172	CARDINAL
ihlr-16574	555	1	173	CARDINAL
ihlr-16574	555	2	8	CARDINAL
ihlr-16574	555	3	174	CARDINAL
ihlr-16574	556	1	80	CARDINAL
ihlr-16574	557	1	175	CARDINAL
ihlr-16574	558	1	422	CARDINAL
ihlr-16574	558	2	indiana	GPE
ihlr-16574	559	1	etp	ORG
ihlr-16574	559	2	one day	DATE
ihlr-16574	559	3	fda	ORG
ihlr-16574	560	1	nanomedicine	PERSON
ihlr-16574	562	1	178	CARDINAL
ihlr-16574	563	1	1	CARDINAL
ihlr-16574	565	1	first	ORDINAL
ihlr-16574	566	1	180	CARDINAL
ihlr-16574	570	1	133	CARDINAL
ihlr-16574	570	2	24	CARDINAL
ihlr-16574	570	3	177	CARDINAL
ihlr-16574	571	1	80	CARDINAL
ihlr-16574	571	2	4	CARDINAL
ihlr-16574	571	3	178	CARDINAL
ihlr-16574	572	1	133	CARDINAL
ihlr-16574	572	2	24	CARDINAL
ihlr-16574	572	3	179	CARDINAL
ihlr-16574	573	1	jordan saltzberg	PERSON
ihlr-16574	573	2	29	CARDINAL
ihlr-16574	574	1	505	CARDINAL
ihlr-16574	574	2	505	CARDINAL
ihlr-16574	574	3	2008	DATE
ihlr-16574	575	1	180	CARDINAL
ihlr-16574	576	1	506	CARDINAL
ihlr-16574	576	2	uw-madison	GPE
ihlr-16574	576	3	http:// www.news.wisc.edu/packages/stemcells/facts.html	GPE
ihlr-16574	576	4	feb. 13, 2008	DATE
ihlr-16574	577	1	181	CARDINAL
ihlr-16574	578	1	saltzberg	PERSON
ihlr-16574	578	2	supra	PERSON
ihlr-16574	578	3	179	CARDINAL
ihlr-16574	578	4	506	CARDINAL
ihlr-16574	579	1	2010	DATE
ihlr-16574	579	2	nanomedicine 423	LAW
ihlr-16574	580	1	182	CARDINAL
ihlr-16574	583	1	183	CARDINAL
ihlr-16574	585	1	five to nine days	DATE
ihlr-16574	587	1	186	CARDINAL
ihlr-16574	590	1	182	CARDINAL
ihlr-16574	591	1	183	CARDINAL
ihlr-16574	593	1	507	CARDINAL
ihlr-16574	597	1	2	CARDINAL
ihlr-16574	597	2	2004	DATE
ihlr-16574	598	1	pdf	ORG
ihlr-16574	598	2	congress	ORG
ihlr-16574	599	1	185	CARDINAL
ihlr-16574	600	1	saltzberg	PERSON
ihlr-16574	600	2	supra	PERSON
ihlr-16574	600	3	179	CARDINAL
ihlr-16574	600	4	512	CARDINAL
ihlr-16574	601	1	186	CARDINAL
ihlr-16574	601	2	187	CARDINAL
ihlr-16574	602	1	505	CARDINAL
ihlr-16574	603	1	188	CARDINAL
ihlr-16574	604	1	517	CARDINAL
ihlr-16574	605	1	189	CARDINAL
ihlr-16574	607	1	d.	NORP
ihlr-16574	607	2	carly goldstein	PERSON
ihlr-16574	607	3	uncle sam's	PERSON
ihlr-16574	607	4	11	CARDINAL
ihlr-16574	608	1	229	CARDINAL
ihlr-16574	608	2	256	CARDINAL
ihlr-16574	608	3	2002	DATE
ihlr-16574	609	1	424	CARDINAL
ihlr-16574	609	2	indiana health law review	ORG
ihlr-16574	610	1	7:397 2	CARDINAL
ihlr-16574	610	2	u.s.	GPE
ihlr-16574	610	3	eu	ORG
ihlr-16574	610	4	nanomedicine	PERSON
ihlr-16574	616	1	nanomedicine	PERSON
ihlr-16574	616	2	the united states	GPE
ihlr-16574	616	3	the european union	ORG
ihlr-16574	619	1	nanomedicine	PERSON
ihlr-16574	622	1	nanomedicine	ORG
ihlr-16574	623	1	the united states	GPE
ihlr-16574	623	2	the european union	ORG
ihlr-16574	624	1	nanomedicine	PERSON
ihlr-16574	625	1	nanomedicine	PERSON
ihlr-16574	625	2	191	CARDINAL
ihlr-16574	627	1	bioetincs	ORG
ihlr-16574	627	2	6	CARDINAL
ihlr-16574	629	1	140	CARDINAL
ihlr-16574	630	1	2010	DATE
ihlr-16574	630	2	425	CARDINAL
ihlr-16574	631	1	nanomedicine technology	ORG
ihlr-16574	632	1	the united states	GPE
ihlr-16574	632	2	the european union	ORG
ihlr-16574	634	1	nanomedicine	PERSON
ihlr-16574	636	1	nanomedicine	ORG
ihlr-16574	639	1	the united states	GPE
ihlr-16574	639	2	the european union	ORG
ihlr-16574	639	3	nanomedicine regula­ tion	PERSON
ihlr-16574	644	1	the united states	GPE
ihlr-16574	644	2	the european union	ORG
ihlr-16574	646	1	today	DATE
ihlr-16574	648	1	192	CARDINAL
ihlr-16574	649	1	paramount television broadcast	ORG
ihlr-16574	649	2	february	DATE
ihlr-16574	649	3	1989	DATE